Sarah Einerhand

Disclosure information not submitted.

Presentation(s):

• MP03-06: Prospective study on FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer

  Friday, May 13, 2022
  7:00 AM – 8:15 AM